CClinicalTrials.gg
CompletedNCT00662402Updated Oct 11, 2018

Impact of Extensive Consultation on Career Development Grant Outcomes

An interventional study of Extensive Consultations in Career Development Grant Outcomes, sponsored by University of California, San Francisco. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2018-10-11.

Sponsored by University of California, San Francisco · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
132
Allocation
Randomized
Sex
All
01

Study summary

In this study we wish is to determine whether extensive (up to 15 hours) multidisciplinary consultation in biostatistics, study design, data management, ethics, and writing provided by the UCSF Clinical and Translational Science Institute's (CTSI) Consultation Services program, improves peer review scores of career development grants compared to usual levels of consultation.

We hypothesize that extensive multidisciplinary consultation will improve peer review scores of career development grants compared to usual levels of consultation.

We hypothesize that extensive multidisciplinary consultation will lead to greater numbers of funded grants when compared to the usual levels of consultation.

Read the detailed description

CTSI Consultation Services is one of the largest programs within the UCSF CTSI. It was created to improve the quality and efficiency of clinical and translational research through the provision of expert consultation. The program is divided into units that provide access to expert consultants in biostatistics, research design (with consultants representing multiple distinct methodologies and disease interests), data management (including data structure and database design), ethics, and scientific writing. With funding from the NIH, the program is able to offer a free hour of consultation in each of its units (up to 4 hours) but charges for additional services to cover costs.

There have been no studies of research consultation services. Though the benefit may seem self evident, such programs are expensive and distract senior researcher from more creative work. Justifying research consultation is important given the multitude of activities vying for attention and funding. Observational studies of the impact of research consultation services will always be limited by confounding, particularly confounding by indication since those seeking such services may be more highly motivated and organized. Thus, a randomized trial is warranted.

02

Conditions studied

  • Career Development Grant Outcomes

Keywords

  • K Grant
  • Career Advancement
  • Award
  • Consultation
  • Application
  • K
  • The NIH priority score of the reviewed proposal.
  • Percent of subjects who obtain funding for proposal.
  • Percent of subjects who submit proposals for funding.
03

In context

Lead sponsor

University of California, San Francisco is the lead sponsor of 2,132 studies on the registry; 375 are open to participants now.

Of its 262 completed or terminated interventional studies of FDA-regulated products, 196 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  • Applying for a Career Development grant from the NIH.
  • Anticipated submission date is 3 or more months in the future
  • Resident, fellow, or junior faculty member at UCSF or a CTSI-affiliated institution.
  • Recognized potential benefit from additional consultation

    • Additional areas that could be improved as judged by the subject and the initial consultant
    • Adequate time to provide consultation before submission date
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
132 participants (actual)

Study arms

  • Experimental
    1-Extensive Consultations

    Intervention- Receives extensive consulting services

    Other: Extensive Consultations

  • No intervention
    2-Regular levels of service

    Control - Receives regular levels of service; one hour free services from each of the 4 units, with option to pay for more.

Interventions

  • OtherExtensive Consultations

    receives 15 free hours of multidisciplinary consultations towards the preparation of their career development grant.

    Also known as: Consultations, Extensive Multi-disciplinary Consultations

06

What researchers measure

Primary outcomes

  1. NIH priority score of the reviewed proposal, with unsubmitted or unscored proposals counted as priority scores that are right-censored at 300 (old system) or 50 (new system)

    Time frame: 30 Months

Secondary outcomes

  1. Percentage of subjects who obtain funding for the submitted proposal

    Time frame: 30 Months

  2. Institute-specific percentile of the priority score

    Time frame: 30 Months

  3. Percentage of subjects who submit proposals for funding

    Time frame: 30 Months

  4. Percentage of subjects who received a good score (<40 or <200) which may be associated with future funding of a resubmission

    Time frame: 30 Months

  5. Percentage of subjects who obtained any career development award funding

    Time frame: 30 Months

07

Study locations

1 site
  • University of California, San Francisco
    San Francisco, California 94144, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 11, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00662402
Lead sponsor
University of California, San Francisco
Responsible party
Sponsor
First posted
Apr 21, 2008
Start date
Apr 2008
Primary completion
Jul 30, 2018
Completion
Jul 30, 2018
Last update
Oct 11, 2018

Study contacts

Alka Kanaya, MD
principal investigator · University of California, San Francisco
Peter Bacchetti, PhD
study director · University of California, San Francisco
Clay Johnston, MD, PhD
study director · University of California, San Francisco

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion